https://doi.org/10.4081/amsa.2023.29
Vincenzo Tiberio, interspecies competition and infection control strategies
Submitted: 19 July 2023
Accepted: 11 October 2023
Published: 27 November 2023
Accepted: 11 October 2023
Abstract Views: 690
PDF: 51
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
The following paper sums up the history of Dr. Vincenzo Tiberio, a military physician from Italy, who lived around the second half of the past century. His life was dedicated to clinical research, particularly in the context of microorganism competition and mechanisms of transmission of infections. His scientific work, though significant and innovative, was adequately appreciated just many years after his death; a great loss for the scientific world since his discovery could have laid the groundwork for the development of antimicrobial drugs that can be used nowadays in the infection control strategies.
Mohr KI. History of antibiotics research. Curr Top Microbiol Immunol 2016;398:237-272.
DOI: https://doi.org/10.1007/82_2016_499
Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 2010;1:134.
DOI: https://doi.org/10.3389/fmicb.2010.00134
Sgambato F, Caporaso C, Sepino PP. Vincenzo Tiberio e il pozzo. Le lezioni di Storia della Medicina. Incontri regionali di Medicina Interna- FADOI Campania-Molise Available from: http://incontrialcasale.casalerosamelia.com/wp-content/uploads/2019/11/TIBERIO_VINCENZO_PENICILLINA.pdf
Vuillemin P. Antibiose and Symbiose. Association française pour l'avancement des sciences; 1889.
Bucci R, Galli P. Vincenzo Tiberio: a misunderstood researcher. Ital J Public Health 2011;8:404-406.
Tiberio V. Sugli estratti di alcune muffe. Annali di Igiene Sperimentale1895;5.
Fleming A. On the Antibacterial Action of Cultures of a Penicillium, with Special Reference to their Use in the Isolation of B. influenzæ. Br J Exp Pathol 1929;10:226–36.
The Nobel Prize in Physiology or Medicine 1945. Available from: https://www.nobelprize.org/prizes/medicine/1945/summary/
Timsit JF, Bassetti M, Cremer O, et al. Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med 2019;45:172-189.
DOI: https://doi.org/10.1007/s00134-019-05520-5
Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 2010;8:15-25.
Ruiz J, Gordon M, Villarreal E, et al. Influence of antibiotic pressure on multi-drug resistant Klebsiella pneumoniae colonisation in critically ill patients. Antimicrob Resist Infect Control 2019;8:38.
DOI: https://doi.org/10.1186/s13756-019-0484-8
Ahn JY, Ahn SM, Kim JH, et al. Clinical Characteristics and Associated Factors for Mortality in Patients with Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection. Microorganisms 2023;11:1121.
DOI: https://doi.org/10.3390/microorganisms11051121
Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin. Microbiol Infect 2011;17:1798–1803.
DOI: https://doi.org/10.1111/j.1469-0691.2011.03514.x
Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clin Infect Dis 2018;67:1803–1814.
DOI: https://doi.org/10.1093/cid/ciy378
Spellberg B. The New Antibiotic Mantra-"Shorter Is Better". JAMA Intern Med 2016;176:1254-5.
DOI: https://doi.org/10.1001/jamainternmed.2016.3646
Cortegiani A, Antonelli M, Falcone M, et al. Rationale and clinical application of antimicrobial stewardship principles in the intensive care unit: a multidisciplinary statement. J Anesth Analg Crit Care 2023;3:11.
DOI: https://doi.org/10.1186/s44158-023-00095-6
Martines V. Vincenzo Tiberio: l’Uomo, il Ricercatore, l’Ufficiale [The Man, the Researcher, the Officer]. G Med Mil 1995;4:511-28;
Martines V, La Torre G. Vincenzo Tiberio, precursore degli studi sulla penicillina [Vincenzo Tiberio, a precursor of the studies on Penicillin]. Ann Ig 1996;8:325-7.
Hibbing ME, Fuqua C, Parsek MR, Peterson SB. Bacterial competition: surviving and thriving in the microbial jungle. Nat Rev Microbiol 2010;8:15-25.
DOI: https://doi.org/10.1038/nrmicro2259
La penicillina scoperta a Sepino, ma Vincenzo Tiberio è sconosciuto. la Repubblica, 24/05/2021. Available from: https://www.repubblica.it/dossier/cronaca/turismo-2021/2021/05/24/news/la_penicillina_scoperta_a_sepino_ma_vincenzo_tiberio_e_sconosciuto-302371770/#:~:text=La%20penicillina%20scoperta%20a%20Sepino%2C%20ma%20Vincenzo%20Tiberio%20%C3%A8%20sconosciuto,-di%20Cristina%20Nadotti&text=Alaxander%20Fleming%20ha%20il%20Nobel,dove%20era%20nato%20nel%201869
Jeffrey M, Denny KJ, Lipman J, Conway Morris A. Differentiating infection, colonisation, and sterile inflammation in critical illness: the emerging role of host-response profiling. Intensive Care Med 2023;49:760-771.
DOI: https://doi.org/10.1007/s00134-023-07108-6
How to Cite
Tocco, M., Venditto, A., Gasperoni, E., Rinaldi, E., & Russo, E. (2023). Vincenzo Tiberio, interspecies competition and infection control strategies. Acute Care Medicine Surgery and Anesthesia, 1(1). https://doi.org/10.4081/amsa.2023.29
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.